{"id":44797,"date":"2025-12-20T19:39:34","date_gmt":"2025-12-20T10:39:34","guid":{"rendered":"https:\/\/www.marketresearchcenter.net\/data\/?p=44797"},"modified":"2025-12-20T19:39:34","modified_gmt":"2025-12-20T10:39:34","slug":"ewing-sarcoma-therapeutics-market","status":"publish","type":"post","link":"https:\/\/www.marketresearchcenter.net\/data\/ewing-sarcoma-therapeutics-market\/","title":{"rendered":"\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u6cbb\u7642\u5e02\u5834\uff1a\u6cbb\u7642\u6cd5\uff08\u5316\u5b66\u7642\u6cd5\u3001\u514d\u75ab\u7642\u6cd5\u3001\u653e\u5c04\u7dda\u7642\u6cd5\uff09\u5225\u3001\u85ac\u52b9\u5206\u985e\uff08\u30a2\u30eb\u30ad\u30eb\u5316\u5264\u3001\u30a2\u30f3\u30c8\u30e9\u30b5\u30a4\u30af\u30ea\u30f3\u7cfb\u85ac\u5264\u3001\u30c8\u30dd\u30a4\u30bd\u30e1\u30e9\u30fc\u30bc\u963b\u5bb3\u5264\uff09\u5225\u3001\u6295\u4e0e\u7d4c\u8def\u5225\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5e74\u9f62\u5c64\u5225 – \u4e16\u754c\u5e02\u5834\u4e88\u6e2c 2025-2032\u5e74"},"content":{"rendered":"

\"Market<\/p>\n

\u4ee5\u4e0b\u306b\u3001\u3054\u6307\u5b9a\u306e\u300cBasic TOC\u300d\u3068\u300cSegmentation Details\u300d\u306b\u57fa\u3065\u304d\u3001\u8a73\u7d30\u306a\u968e\u5c64\u69cb\u9020\u3092\u6301\u3064\u65e5\u672c\u8a9e\u306e\u76ee\u6b21\u3092\u69cb\u7bc9\u3057\u307e\u3057\u305f\u3002CRITICAL\u6307\u5b9a\u306e\u300c**\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u6cbb\u7642**\u300d\u3068\u3044\u3046\u7528\u8a9e\u306f\u6b63\u78ba\u306b\u4f7f\u7528\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

—<\/p>\n

## \u76ee\u6b21<\/p>\n

1. **\u5e8f\u6587** (Preface)
\n 1.1. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3068\u30ab\u30d0\u30ec\u30c3\u30b8 (Market Segmentation & Coverage)
\n 1.2. \u8abf\u67fb\u5bfe\u8c61\u5e74 (Years Considered for the Study)
\n 1.3. \u901a\u8ca8 (Currency)
\n 1.4. \u8a00\u8a9e (Language)
\n 1.5. \u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc (Stakeholders)
\n2. **\u8abf\u67fb\u65b9\u6cd5** (Research Methodology)
\n3. **\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc** (Executive Summary)
\n4. **\u5e02\u5834\u6982\u8981** (Market Overview)
\n5. **\u5e02\u5834\u30a4\u30f3\u30b5\u30a4\u30c8** (Market Insights)
\n 5.1. \u8ee2\u79fb\u6027\u304a\u3088\u3073\u518d\u767a\u6027\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u60a3\u8005\u96c6\u56e3\u306b\u304a\u3051\u308b\u8ee2\u5e30\u6539\u5584\u306e\u305f\u3081\u306e\u81ea\u5bb6\u5e79\u7d30\u80de\u30ec\u30b9\u30ad\u30e5\u30fc\u30d7\u30ed\u30c8\u30b3\u30eb\u3092\u7528\u3044\u305f\u9ad8\u7528\u91cf\u5316\u5b66\u7642\u6cd5\u306e\u6700\u9069\u5316 (Optimization of high-dose chemotherapy with autologous stem cell rescue protocols to improve outcomes in metastatic and recurrent Ewing sarcoma populations)
\n 5.2. \u5e74\u9f62\u7279\u7570\u7684\u306a\u751f\u7269\u5b66\u3001\u6295\u4e0e\u91cf\u3001\u304a\u3088\u3073\u751f\u5b58\u30cb\u30fc\u30ba\u306b\u5bfe\u5fdc\u3059\u308b\u9752\u5e74\u304a\u3088\u3073\u82e5\u5e74\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u8a66\u9a13\u3078\u306e\u91cd\u70b9\u306e\u9ad8\u307e\u308a (Growing emphasis on adolescent and young adult\u2013focused Ewing sarcoma trials addressing age-specific biology, dosing, and survivorship needs)
\n 5.3. \u518d\u767a\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306b\u304a\u3051\u308b\u594f\u52b9\u7387\u306e\u6539\u5584\u3092\u793a\u3059IGF-1R\u304a\u3088\u3073FET\u878d\u5408\u6a19\u7684\u7642\u6cd5\u306e\u51fa\u73fe (Emergence of IGF-1R and FET fusion targeted therapies demonstrating improved response rates in relapsed Ewing sarcoma)
\n 5.4. \u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306b\u304a\u3051\u308b\u5c0f\u5150\u6cbb\u7642\u85ac\u306e\u627f\u8a8d\u52a0\u901f\u3092\u63a8\u9032\u3059\u308b\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u306e\u898f\u5236\u4e0a\u306e\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6 (Regulatory incentives for orphan drug designation driving accelerated pediatric therapeutic approvals in Ewing sarcoma)
\n 5.5. \u4e16\u754c\u7684\u306a\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u69cb\u7bc9\u3057\u3001\u60a3\u8005\u52df\u96c6\u3092\u5897\u3084\u3059\u305f\u3081\u306e\u5b66\u8853\u8089\u816b\u30bb\u30f3\u30bf\u30fc\u3068\u696d\u754c\u30b9\u30dd\u30f3\u30b5\u30fc\u9593\u306e\u6226\u7565\u7684\u63d0\u643a (Strategic collaborations between academic sarcoma centers and industry sponsors to build global Ewing sarcoma trial networks and increase patient recruitment)
\n 5.6. \u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306e\u65e9\u671f\u767a\u898b\u3068\u52d5\u7684\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306e\u305f\u3081\u306e\u30ea\u30ad\u30c3\u30c9\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u5faa\u74b0\u816b\u760dDNA\u30a2\u30c3\u30bb\u30a4\u306e\u7d71\u5408 (Integration of liquid biopsy circulating tumor DNA assays for early detection and dynamic monitoring of Ewing sarcoma)
\n 5.7. \u6cbb\u7642\u53cd\u5fdc\u3092\u4e88\u6e2c\u3057\u3001\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u60a3\u8005\u3092\u5c64\u5225\u5316\u3059\u308b\u305f\u3081\u306eAI\u99c6\u52d5\u578b\u30e9\u30b8\u30aa\u30df\u30af\u30b9\u753b\u50cf\u89e3\u6790\u306e\u63a1\u7528 (Adoption of AI-driven radiomic imaging analytics to predict therapeutic response and stratify Ewing sarcoma patients)
\n 5.8. \u96e3\u6cbb\u6027\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306b\u304a\u3051\u308b\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u3068\u990a\u5b50\u7d30\u80de\u7642\u6cd5\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u4f75\u7528\u514d\u75ab\u7642\u6cd5\u306e\u9032\u5c55 (Advances in combination immunotherapy leveraging checkpoint inhibitors with adoptive cell therapy in refractory Ewing sarcoma)
\n 5.9. \u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306e\u7b2cI\/II\u76f8\u8a66\u9a13\u306b\u304a\u3051\u308b\u500b\u5225\u5316\u30cd\u30aa\u30a2\u30f3\u30c1\u30b2\u30f3\u30da\u30d7\u30c1\u30c9\u30ef\u30af\u30c1\u30f3\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u62e1\u5927 (Expansion of personalized neoantigen peptide vaccine platforms in phase I\/II Ewing sarcoma studies)
\n 5.<\/p>\n","protected":false},"excerpt":{"rendered":"

**\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u6cbb\u7642\u5e02\u5834\u306e\u6982\u8981\u3001\u63a8\u9032\u8981\u56e0\u3001\u304a\u3088\u3073\u5c55\u671b**<\/p>\n

**\u5e02\u5834\u6982\u8981**
\n\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u6cbb\u7642\u5e02\u5834\u306f\u30012024\u5e74\u306b8\u51045,151\u4e07\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012025\u5e74\u306b\u306f9\u5104992\u4e07\u7c73\u30c9\u30eb\u306b\u9054\u3057\u30012032\u5e74\u307e\u3067\u306b14\u51047,980\u4e07\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f7.15%\u3067\u3059\u3002\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306f\u3001\u5c0f\u5150\u9aa8\u764c\u306e\u4e2d\u3067\u3082\u7279\u306b\u9032\u884c\u304c\u901f\u3044\u5f62\u614b\u306e\u4e00\u3064\u3067\u3042\u308a\u3001\u5f93\u6765\u306e\u5316\u5b66\u7642\u6cd5\u3084\u5916\u79d1\u7684\u4ecb\u5165\u3092\u8d85\u3048\u305f\u591a\u89d2\u7684\u306a\u6cbb\u7642\u30a2\u30d7\u30ed\u30fc\u30c1\u304c\u6c42\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u904e\u53bb10\u5e74\u9593\u3067\u3001\u7814\u7a76\u8005\u305f\u3061\u306f\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306e\u5206\u5b50\u30c9\u30e9\u30a4\u30d0\u30fc\u3001\u7279\u306b\u75be\u60a3\u75c5\u614b\u306e\u57fa\u790e\u3068\u306a\u308bEWS-FLI1\u878d\u5408\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u89e3\u660e\u306b\u304a\u3044\u3066\u76ee\u899a\u307e\u3057\u3044\u9032\u6b69\u3092\u9042\u3052\u307e\u3057\u305f\u3002\u3053\u306e\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u306f\u3001\u3088\u308a\u9ad8\u3044\u7cbe\u5ea6\u3068\u5c11\u306a\u3044\u30aa\u30d5\u30bf\u30fc\u30b2\u30c3\u30c8\u52b9\u679c\u3067\u764c\u907a\u4f1d\u5b50\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u7d4c\u8def\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u305f\u3001\u65b0\u3057\u3044\u6a19\u7684\u7642\u6cd5\u3084\u514d\u75ab\u7642\u6cd5\u306e\u63a2\u7d22\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u30b2\u30ce\u30e0\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\u3068\u6b21\u4e16\u4ee3\u30b7\u30fc\u30b1\u30f3\u30b7\u30f3\u30b0\u306e\u9032\u6b69\u306b\u3088\u308a\u3001\u60a3\u8005\u306e\u5c64\u5225\u5316\u304c\u3088\u308a\u6b63\u78ba\u306b\u306a\u308a\u3001\u9032\u5316\u3059\u308b\u816b\u760d\u74b0\u5883\u306b\u9069\u5fdc\u3057\u305f\u500b\u5225\u5316\u6cbb\u7642\u30ec\u30b8\u30e1\u30f3\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u7cbe\u5bc6\u816b\u760d\u5b66\u3078\u306e\u79fb\u884c\u304c\u9032\u3080\u4e2d\u3001\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u3001CAR T\u7d30\u80de\u6280\u8853\u3001\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u6d3b\u7528\u3057\u3066\u6301\u7d9a\u7684\u306a\u53cd\u5fdc\u3092\u5f15\u304d\u51fa\u3059\u3053\u3068\u3078\u306e\u95a2\u5fc3\u304c\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u65b0\u305f\u306a\u6226\u7565\u306f\u3001\u653e\u5c04\u7dda\u6cbb\u7642\u8a08\u753b\u3068\u60a3\u80a2\u6e29\u5b58\u624b\u8853\u6280\u8853\u306e\u6539\u826f\u3068\u76f8\u307e\u3063\u3066\u3001\u6cbb\u7642\u306e\u6a19\u6e96\u3092\u518d\u69cb\u7bc9\u3057\u3001\u7f79\u60a3\u60a3\u8005\u306e\u751f\u5b58\u7387\u3068\u751f\u6d3b\u306e\u8cea\u306e\u5411\u4e0a\u306b\u65b0\u305f\u306a\u5e0c\u671b\u3092\u3082\u305f\u3089\u3057\u59cb\u3081\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u80cc\u666f\u304b\u3089\u3001\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u6cbb\u7642\u5e02\u5834\u306f\u3001\u5805\u8abf\u306a\u7814\u7a76\u958b\u767a\u6295\u8cc7\u3001\u7570\u696d\u7a2e\u9593\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3001\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u958b\u767a\u306b\u5bfe\u3059\u308b\u898f\u5236\u4e0a\u306e\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u306b\u5f8c\u62bc\u3057\u3055\u308c\u3001\u5909\u9769\u7684\u306a\u6210\u9577\u3092\u9042\u3052\u308b\u614b\u52e2\u304c\u6574\u3063\u3066\u3044\u307e\u3059\u3002\u5b66\u8853\u754c\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u88fd\u85ac\u696d\u754c\u306e\u5229\u5bb3\u95a2\u4fc2\u8005\u306f\u3001\u81e8\u5e8a\u3078\u306e\u8fc5\u901f\u306a\u79fb\u884c\u3001\u5e02\u5834\u6295\u5165\u307e\u3067\u306e\u6642\u9593\u306e\u77ed\u7e2e\u3001\u65b0\u898f\u85ac\u5264\u3078\u306e\u30a2\u30af\u30bb\u30b9\u62e1\u5927\u306e\u5fc5\u8981\u6027\u306b\u3064\u3044\u3066\u307e\u3059\u307e\u3059\u8a8d\u8b58\u3092\u5171\u6709\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

**\u63a8\u9032\u8981\u56e0**
\n\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u6cbb\u7642\u306e\u72b6\u6cc1\u306f\u3001\u5206\u5b50\u751f\u7269\u5b66\u3068\u514d\u75ab\u5b66\u306b\u304a\u3051\u308b\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u304c\u6cbb\u7642\u306e\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2\u3092\u518d\u5b9a\u7fa9\u3059\u308b\u306b\u3064\u308c\u3066\u3001\u5927\u304d\u304f\u5909\u9769\u3055\u308c\u307e\u3057\u305f\u3002\u6b74\u53f2\u7684\u306b\u591a\u5264\u4f75\u7528\u5316\u5b66\u7642\u6cd5\u306b\u4f9d\u5b58\u3057\u3066\u3044\u307e\u3057\u305f\u304c\u3001\u73fe\u5728\u3067\u306fEWS-FLI1\u878d\u5408\u6d3b\u6027\u3068\u4e0b\u6d41\u306e\u30a8\u30d5\u30a7\u30af\u30bf\u30fc\u3092\u963b\u5bb3\u3059\u308b\u3088\u3046\u306b\u8a2d\u8a08\u3055\u308c\u305f\u7cbe\u5bc6\u8a98\u5c0e\u6a19\u7684\u7642\u6cd5\u304c\u7d71\u5408\u3055\u308c\u3066\u3044\u307e\u3059\u3002CAR T\u7d30\u80de\u69cb\u7bc9\u7269\u3084\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u306e\u5c0e\u5165\u306f\u3001\u6301\u7d9a\u7684\u306a\u6297\u816b\u760d\u53cd\u5fdc\u306e\u305f\u3081\u306e\u65b0\u305f\u306a\u9053\u7b4b\u3092\u958b\u304d\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u6cbb\u7642\u306e\u9032\u6b69\u306f\u3001\u6db2\u4f53\u751f\u691c\u30a2\u30c3\u30bb\u30a4\u3084PET\/MRI\u878d\u5408\u6280\u8853\u306a\u3069\u306e\u65e9\u671f\u767a\u898b\u30fb\u8a3a\u65ad\u753b\u50cf\u8a3a\u65ad\u306e\u9032\u6b69\u306b\u3088\u3063\u3066\u88dc\u5b8c\u3055\u308c\u3001\u6cbb\u7642\u52b9\u679c\u306e\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3068\u518d\u767a\u691c\u51fa\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u6a19\u7684\u85ac\u5264\u3068\u514d\u75ab\u8abf\u7bc0\u5264\u3092\u76f8\u4e57\u3055\u305b\u308b\u4f75\u7528\u30ec\u30b8\u30e1\u30f3\u3078\u306e\u91cd\u70b9\u306f\u3001\u6bd2\u6027\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u306a\u304c\u3089\u81e8\u5e8a\u7684\u5229\u76ca\u3092\u6700\u5927\u5316\u3059\u308b\u500b\u5225\u5316\u3055\u308c\u305f\u591a\u89d2\u7684\u6226\u7565\u3078\u306e\u30b7\u30d5\u30c8\u3092\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002\u898f\u5236\u9762\u3067\u306f\u3001\u5e0c\u5c11\u75be\u60a3\u9069\u5fdc\u75c7\u306b\u5bfe\u3059\u308b\u8fc5\u901f\u627f\u8a8d\u7d4c\u8def\u3068\u9069\u5fdc\u7684\u8a66\u9a13\u30c7\u30b6\u30a4\u30f3\u304c\u3001\u7814\u7a76\u5ba4\u304b\u3089\u81e8\u5e8a\u3078\u306e\u79fb\u884c\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u5171\u540c\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0\u3068\u5b98\u6c11\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u3001\u30ea\u30bd\u30fc\u30b9\u3092\u5171\u6709\u3057\u3001\u30d7\u30ed\u30c8\u30b3\u30eb\u3092\u8abf\u548c\u3055\u305b\u3001\u30c7\u30fc\u30bf\u5171\u6709\u304c\u8fc5\u901f\u306a\u53cd\u5fa9\u3092\u4fc3\u9032\u3059\u308b\u74b0\u5883\u3092\u80b2\u3093\u3067\u3044\u307e\u3059\u3002<\/p>\n

\u5e02\u5834\u306e\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3082\u91cd\u8981\u306a\u63a8\u9032\u8981\u56e0\u3067\u3059\u3002\u6cbb\u7642\u6cd5\u30bf\u30a4\u30d7\u5225\u3067\u306f\u3001\u5316\u5b66\u7642\u6cd5\uff08\u9ad8\u7528\u91cf\/\u6a19\u6e96\u30ec\u30b8\u30e1\u30f3\uff09\u3001\u514d\u75ab\u7642\u6cd5\uff08CAR T\u7d30\u80de\/\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\uff09\u3001\u653e\u5c04\u7dda\u7642\u6cd5\uff08\u30d6\u30e9\u30ad\u30bb\u30e9\u30d4\u30fc\/\u5916\u90e8\u7167\u5c04\uff09\u3001\u5916\u79d1\u7684\u4ecb\u5165\uff08\u60a3\u80a2\u5207\u65ad\/\u60a3\u80a2\u6e29\u5b58\u624b\u8853\uff09\u3001\u6a19\u7684\u7642\u6cd5\uff08\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\/\u4f4e\u5206\u5b50\u963b\u5bb3\u5264\uff09\u306b\u7d30\u5206\u5316\u3055\u308c\u307e\u3059\u3002\u60a3\u8005\u96c6\u56e3\u306f\u3001\u65b0\u305f\u306b\u8a3a\u65ad\u3055\u308c\u305f\u60a3\u8005\u3068\u518d\u767a\u30fb\u96e3\u6cbb\u6027\u60a3\u8005\u306b\u5206\u3051\u3089\u308c\u3001\u305d\u308c\u305e\u308c\u5c0f\u5150\u3001\u9752\u5e74\u30fb\u82e5\u5e74\u6210\u4eba\u3001\u6210\u4eba\u96c6\u56e3\u306e\u5e74\u9f62\u5c64\u5225\u306b\u5c64\u5225\u5316\u3055\u308c\u307e\u3059\u3002\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u306f\u3001\u5916\u6765\u8a3a\u7642\u6240\u3001\u75c5\u9662\u3001\u5c02\u9580\u30af\u30ea\u30cb\u30c3\u30af\u306b\u53ca\u3073\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u306f\u75c5\u9662\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3001\u5c0f\u58f2\u5e97\u306a\u3069\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u3053\u306e\u968e\u5c64\u5316\u3055\u308c\u305f\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u30d5\u30ec\u30fc\u30e0\u30ef\u30fc\u30af\u306f\u3001\u6cbb\u7642\u6cd5\u306e\u597d\u307f\u3001\u60a3\u8005\u306e\u4eba\u53e3\u7d71\u8a08\u3001\u6cbb\u7642\u30ed\u30b8\u30b9\u30c6\u30a3\u30af\u30b9\u3001\u304a\u3088\u3073\u30c1\u30e3\u30cd\u30eb\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u306e\u76f8\u4e92\u4f5c\u7528\u3092\u660e\u3089\u304b\u306b\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u6226\u7565\u7684\u610f\u601d\u6c7a\u5b9a\u3092\u652f\u63f4\u3057\u307e\u3059\u3002<\/p>\n

\u5730\u7406\u7684\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3082\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u6cbb\u7642\u5e02\u5834\u306e\u7af6\u4e89\u74b0\u5883\u3092\u5f62\u6210\u3059\u308b\u4e0a\u3067\u6975\u3081\u3066\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u3044\u307e\u3059\u3002\u30a2\u30e1\u30ea\u30ab\u5e02\u5834\u306f\u3001\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u958b\u767a\u306b\u5bfe\u3059\u308b\u5805\u56fa\u306a\u898f\u5236\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u3001\u5e83\u7bc4\u306a\u81e8\u5e8a\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3001\u6148\u5584\u8cc7\u91d1\u306b\u3088\u3063\u3066\u7279\u5fb4\u4ed8\u3051\u3089\u308c\u307e\u3059\u3002\u7c73\u56fd\u3068\u30ab\u30ca\u30c0\u306e\u898f\u5236\u74b0\u5883\u306f\u3001\u8fc5\u901f\u306a\u627f\u8a8d\u7d4c\u8def\u3092\u5968\u52b1\u3057\u3001\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u304c\u3088\u308a\u901f\u3044\u30b9\u30d4\u30fc\u30c9\u3068\u898f\u5236\u306e\u67d4\u8edf\u6027\u3092\u3082\u3063\u3066\u81e8\u5e8a\u306b\u5230\u9054\u3067\u304d\u308b\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u3092\u80b2\u3093\u3067\u3044\u307e\u3059\u3002\u6b27\u5dde\u3001\u4e2d\u6771\u3001\u30a2\u30d5\u30ea\u30ab\u5730\u57df\u306f\u3001\u591a\u69d8\u306a\u56fd\u306e\u511f\u9084\u67a0\u7d44\u307f\u3068\u5e0c\u5c11\u75be\u60a3\u653f\u7b56\u306b\u3088\u3063\u3066\u7279\u5fb4\u4ed8\u3051\u3089\u308c\u3001\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u306b\u5bfe\u3057\u3066\u30d7\u30ec\u30df\u30a2\u30e0\u4fa1\u683c\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u304c\u591a\u3044\u3067\u3059\u3002\u6b27\u5dde\u9023\u5408\u306e\u6307\u4ee4\u3068\u5730\u57df\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0\u306f\u3001\u56fd\u5883\u3092\u8d8a\u3048\u305f\u81e8\u5e8a\u5354\u529b\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5e02\u5834\u306f\u3001\u65e5\u672c\u3084\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306e\u3088\u3046\u306a\u6210\u719f\u3057\u305f\u30d8\u30eb\u30b9\u30b1\u30a2\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\uff08\u7cbe\u5bc6\u533b\u7642\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u3068\u9ad8\u5ea6\u306a\u88fd\u9020\u80fd\u529b\u304c\u6b21\u4e16\u4ee3\u6cbb\u7642\u6cd5\u306e\u65e9\u671f\u63a1\u7528\u3092\u63a8\u9032\uff09\u304b\u3089\u3001\u4e2d\u56fd\u3084\u30a4\u30f3\u30c9\u306e\u3088\u3046\u306a\u6025\u901f\u306b\u9032\u5316\u3059\u308b\u74b0\u5883\uff08\u653f\u7b56\u6539\u9769\u3001\u4fdd\u967a\u9069\u7528\u7bc4\u56f2\u306e\u62e1\u5927\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u9769\u65b0\u3078\u306e\u6295\u8cc7\u304c\u73fe\u5730\u3067\u306e\u7814\u7a76\u958b\u767a\u3068\u5546\u696d\u5316\u3092\u52a0\u901f\uff09\u307e\u3067\u3001\u591a\u69d8\u306a\u8ecc\u8de1\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u7af6\u4e89\u74b0\u5883\u306f\u3001\u5927\u898f\u6a21\u306a\u88fd\u85ac\u4f01\u696d\u3068\u6a5f\u654f\u306a\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306e\u7d44\u307f\u5408\u308f\u305b\u306b\u3088\u3063\u3066\u652f\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u591a\u56fd\u7c4d\u4f01\u696d\u306f\u3001\u5e83\u7bc4\u306a\u81e8\u5e8a\u958b\u767a\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u63a8\u9032\u3057\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u88fd\u9020\u62e0\u70b9\u3092\u78ba\u7acb\u3057\u3066\u3044\u307e\u3059\u3002\u5c02\u9580\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u9769\u65b0\u4f01\u696d\u306f\u3001\u6df1\u3044\u79d1\u5b66\u7684\u5c02\u9580\u77e5\u8b58\u3092\u6d3b\u7528\u3057\u3066\u30d5\u30a1\u30fc\u30b9\u30c8\u30a4\u30f3\u30af\u30e9\u30b9\u306e\u30e2\u30c0\u30ea\u30c6\u30a3\u3092\u8ffd\u6c42\u3057\u3001\u3057\u3070\u3057\u3070\u5b66\u8853\u6a5f\u95a2\u3068\u5354\u529b\u3057\u3001\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u306e\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u3092\u6d3b\u7528\u3057\u3066\u3044\u307e\u3059\u3002\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306f\u3001\u4f4e\u5206\u5b50\u963b\u5bb3\u5264\u304b\u3089\u514d\u75ab\u30d9\u30fc\u30b9\u306e\u6226\u7565\uff08CAR T\u7d30\u80de\u7642\u6cd5\u3084\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\u306a\u3069\uff09\u306b\u81f3\u308b\u307e\u3067\u3001\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306e\u591a\u69d8\u5316\u3092\u512a\u5148\u3057\u3066\u3044\u307e\u3059\u3002\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3001\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3001\u5408\u4f75\u30fb\u8cb7\u53ce\u306f\u3001\u7814\u7a76\u958b\u767a\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u62e1\u5927\u3057\u3001\u88dc\u5b8c\u7684\u306a\u6280\u8853\u306b\u30a2\u30af\u30bb\u30b9\u3059\u308b\u305f\u3081\u306b\u4e0d\u53ef\u6b20\u3067\u3059\u3002\u65b0\u8208\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f\u3001\u7cbe\u5bc6\u816b\u760d\u5b66\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3001\u65b0\u898f\u9001\u9054\u30e1\u30ab\u30cb\u30ba\u30e0\u3001\u304a\u3088\u3073\u7d71\u5408\u8a3a\u65ad\u306b\u3088\u3063\u3066\u7279\u5fb4\u4ed8\u3051\u3089\u308c\u3001\u60a3\u8005\u9078\u629e\u3092\u6d17\u7df4\u3057\u6cbb\u7642\u52b9\u679c\u3092\u9ad8\u3081\u308b\u3053\u3068\u3092\u7d04\u675f\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-44797","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/posts\/44797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/comments?post=44797"}],"version-history":[{"count":0,"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/posts\/44797\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/media?parent=44797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/categories?post=44797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearchcenter.net\/data\/wp-json\/wp\/v2\/tags?post=44797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}